Detection of resectable recurrences in colorectal cancer patients with 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography

Cancer Biotherapy and Radiopharmaceuticals

Volumn 28, Issue 6, 2013, Pages 479-487

  Peng, Nan Jing ^a,b   Hu, Chin ^a   King, Tai Ming ^a   Chiu, Yu Li ^a   Wang, Jui Ho ^a   Liu, Ren Shyan ^b,c  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84880892301     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1382     Document Type: Article

References (39)

1. Siegel R, Ward E, Brawley O, et al. Cancer statistics. CA Cancer J Clin 2011;61:212.
2. Detry R. Follow-up after curative surgery for colorectal cancer. Acta Gastroenterol Belg 2001;64:268.
3. Korner H, Soreide K, Stokkeland PJ, et al. Systematic followup after curative surgery for colorectal cancer in Norway: A population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg 2005;9:320.
4. Chau I, Allen MJ, Cunningham D, et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004;22:1420.
5. Kievit J. Follow-up of patients with colorectal cancer: Numbers needed to test and treat. Eur J Cancer 2002;38:986.
6. Minton JP, Hoehn JL, Gerber DM, et al. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985;55:1284.
7. McCall JL, Black RB, Rich CA, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994;37:875.
8. Hine KR, Dykes PW. Serum CEA testing in the postoperative surveillance of colorectal carcinoma. Br J Cancer 1984;49:689.
9. Martin EW Jr., Cooperman M, Carey LC, et al. Sixty secondlook procedures indicated primarily by rise in serial carcinoembryonic antigen. J Surg Res 1980;28:389.
10. Benson AB 3rd, Desch CE, Flynn PJ, et al. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000;18:3586.
11. Huebner RH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole-body FDG PET detection of colorectal cancer. J Nucl Med 2000;41:1177.
12. Gambhir SS, Czernin J, Schimmer J, et al. A tabulated review of the literature. J Nucl Med 2001;42(Suppl):9S.
13. Sobhani J, Tiret E, Aparicio T, et al. Early detection of recurrence by F-18 FDG-PET in the follow-up of patients with colorectal cancer. Bri J Cancer 2008;98:875.
14. Shamim SA, Kumar R, Halanaik D, et al. Role of FDG-PET/CT in detection of recurrent disease in colorectal cancer. Nucl Med Commun 2010;31:590.
15. Chen LB, Tong JL, Song HZ, et al. F-18 FDG PET/CT in detection of recurrence and metastasis of colorectal cancer. World J Gastroenterol 2007;13:5025.
16. Fukunaga H, Sekimoto M, Ikeda M, et al. Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer. Ann Surg Oncol 2005;12:561.
17. Soyka J, Veit-Haibach P, Strobel K, et al. Staging pathways in recurrent CRC: Is contrast-enhanced F-18 FDG PET/CT the diagnostic tool of choice? J Nucl Med 2008;49:354.
18. Votrubova J, Belohlavek O, Jaruskova M, et al. The role of FDG-PET/CT in the detection of recurrent CRC. Eur J Nucl Med Mol Imaging 2006;33:779.
19. Even-Sapir E, Parag Y, Lerman H, et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004;232:815.
20. Kim JH, Czernin J, Allen-Auerbach M, et al. Comparison between F-18 FDG PET, in-line PET/CT, and software fusion for restaging of recurrent CRC. J Nucl Med 2005;46:587.
21. Nakamoto Y, Sakamoto S, Okada T. Clinical value of manual fusion of PET and CT images in patients with suspected recurrent CRC. Am J Roentgenol 2007;188:257.
22. Schmidt GP, Baur-Melnyk A, Haug A, et al. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 2009;19:1366.
23. McAfee MK, Allen MS, Trastek VF, et al. Colorectal lung metastases: Results of surgical excision. Ann Thorac Surg 1992;53:780.
24. Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: A prognostic assessment. J Thorac Cardiovasc Surg 2002;124: 1007.
25. Ike H, Shimada H, Ohki S, et al. Results of aggressive resection of lung metastases from colorectal carcinoma de-tected by intensive follow-up. Dis Colon Rectum 2002; 45:468.
26. Rizk NP, Downey RJ. Resection of pulmonary metastases from colorectal cancer. Semin Thorac Cardiovasc Surg 2002;14:29.
27. Goldberg RM, Fleming TR, Tangen CM, et al. Surgery for recurrent colon cancer: Strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998;129:27.
28. Desch CE, Benson AB 3rd, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005;23: 8512.
29. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313.
30. Hara M, Kanemitsu Y, Hirai T, et al. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: Analysis with likelihood ratio and posttest probability in a follow-up study. Dis Colon Rectum 2008;51:1675.
31. Zeng Z, Cohen AM, Urmacher C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum 1993;36:1063.
32. Bhattacharjya S, Aggarwal R, Davidson BR. Intensive follow-up after liver resection for colorectal liver metastases: Results of combined serial tumour marker estimations and computed tomography of the chest and abdomen-A prospective study. Br J Cancer 2006;95:21.
33. Park IJ, Choi GS, Lim KH, et al. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: Clinical significance of the preoperative level. Ann Surg Oncol 2009;16:3087.
34. Kyoto Y, Momose M, Kondo C, et al. Ability of F-18 FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations. Ann Nucl Med 2010; 24:395.
35. Tutt ANJ, Plunkett TA, Barrington SF, et al. The role of positron emission tomography in the management of colorectal cancer [review]. Colorectal Dis 2004;6:2.
36. Lee JH, Park SG, Jee KN, et al. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level. Nucl Med Commun 2010;31:576.
37. Hillner BE, Siegel BA, Liu D, et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: Initial results from the National Oncologic PET Registry. J Clin Oncol 2008;26:2155.
38. Scott AM, Gunawardana DH, Kelley B, et al. PET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: Results of a multicenter prospective study. J Nucl Med 2008;49:1451.
39. Peng NJ, Liou WS, Liu RS, et al. Early detection of recurrent ovarian cancer in patients with low-level increases in serum CA-125 levels by FDG-PET/CT. Cancer Biother Radiol 2011; 26:175.